Gastrointestinal Stent Market

The report "Gastrointestinal Stent Market By Product (Duodenal, Pancreatic, Colonic, Biliary), Type [Metal (SEMS, Balloon-expandable, Nitinol, Stainless Steel), Plastic, Biodegradable], Application (Colorectal & Stomach Cancer), End User - Global Forecast to 2031" The global gastrointestinal stent market is projected to reach USD 0.82 billion by 2031 from USD 0.62 billion in 2026, at a CAGR of 5.7% during the forecast period.

Browse 480 market data Tables and 65 Figures spread through 500 Pages and in-depth TOC on "Gastrointestinal Stent Market By Product (Duodenal, Pancreatic, Colonic, Biliary), Type [Metal (SEMS, Balloon-expandable, Nitinol, Stainless Steel), Plastic, Biodegradable], Application (Colorectal & Stomach Cancer), End User - Global Forecast to 2031"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/gastrointestinal-gi-stent-market-167758126.html

The gastrointestinal stent market is poised for a robust expansion as prevalent cases of gastrointestinal cancers, benign disorders' incidences, and the upsurge in the adoption of minimally invasive endoscopic surgeries are some of the reasons behind it. Besides, continuous improvements in stent and biomaterial design contribute to the growth potential of the gastrointestinal stent market. The rising need for the management of strictures, obstructions, leaks, and fistula through effective, safe, and cost-effective methods is pushing the presence of self-expanding metal stents (SEMS), biodegradable stents, and drug-eluting stents in the hospital and specialty endoscopy center market.

The latest advancements, such as anti-migration mechanisms, better radial forces, and flexible low-profile delivery systems, along with bio-compatible coatings, help not only increase procedure technical success but also patient outcomes. Besides these, a stronger focus on early treatment, less hospital stay, increasing healthcare spending, and opening up to advanced endoscopic treatment are some of the important factors that are leading to the growing demand for gastrointestinal stents in the market.

By type, the metal stents segment accounted for the largest market share in 2025.

In the gastrointestinal stent market, the metal stents segment accounted for the largest market share in 2025. This dominance is primarily because of their better mechanical strength, greater radial force, and longer patency than other materials, which renders them very effective in handling malignant stenoses and obstructions. Self-expanding metal stents (SEMS) are favored among physicians since they can better fit even very complicated GI anatomies, are less likely to be crushed, and give better clinical results, especially in cancer treatments. Besides that, innovations such as covered and partially covered designs have not only minimized problems like tumor ingrowth and migration but have also played a significant role in their widespread usage in esophageal, biliary, and colonic cases.

By application, the gastrointestinal cancers segment is expected to grow at the highest CAGR during the forecast period.

The gastrointestinal stent segment is expected to grow at the highest CAGR during the forecast period because the rise in incidence rates of various types of cancers all over the world has led to the increased demand for esophageal, colorectal, and gastric cancer treatments. These cancers that lead to luminal obstructions require immediate palliative intervention. In such cases, GI stents are most commonly used as they are capable to bridge the period from presentation to definitive treatment. They are procured for both malignant and benign obstructions to provide patients with symptom relief and eliminate the need for surgical interventions. Besides this, increasing palliative care and cancer diagnosis rates, along with technological developments such as covered and drug-eluting stents, are some of the contributing factors to the faster growth of their usage in oncology settings as opposed to benign indications.

By region, North America accounted for the largest share of the market in 2025.  

In 2025, North America accounted for the largest share of the gastrointestinal stent market. This is mainly because it has a developed healthcare system, a high percentage of minimally invasive endoscopic procedures being performed, and many leading medical device manufacturers are located there. The area also experiences a high number of gastrointestinal cancer cases and other related disorders, which maintains the demand for stent-based operations. Besides, positive reimbursement rules, early introduction of new types of stents such as drug-eluting and biodegradable ones, and a good endoscopist network contribute to the high usage of these devices and help the region keep its leading position in the market.

Key Market Players

The prominent players in the gastrointestinal stent market are Boston Scientific Corporation (US), Cook Medical (US), Medtronic plc (Ireland), Olympus Corporation (Japan), BD (US), M.I.Tech Co., Ltd. (South Korea), W. L. Gore & Associates, Inc. (US), Endo-Flex GmbH (Germany), Micro-Tech (Nanjing) Co., Ltd. (China), Hobbs Medical Inc. (US), Merit Medical Systems, Inc. (US), BVM Medical Limited (UK), STERIS plc (Ireland), ELLA-CS, s.r.o. (Czech Republic), Q3 Medical Group (Netherlands), among others.

Don’t miss out on business opportunities in Gastrointestinal Stent Market. Speak to our analyst and gain crucial industry insights that will help your business grow.

About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]